New blood test may expand scope of liquid biopsies

A new approach to liquid biopsies may overcome limitations of current blood tests to diagnose and monitor cancers, birth defects, organ transplants and autoimmune disorders. The method relies on analyzing fragmentation patterns in the cell-free DNA in an individual, and comparing them to what might be expected for cell death associated with various medical or physiological conditions. For some types of cancers, researchers could identify the anatomical source of the tumor, which could aid in diagnosing metastatic cancers whose origin is unknown.

Read the whole article on Science Daily

More from Science Daily